Stocks

Medical cannabis companies licensed in the United Kingdom are now eligible for listing on the London Stock Exchange.

A new CBD product line by Martha Stewart and Canopy Growth launches this week after more than a year in development.

New York-based Columbia Care has agreed to acquire Project Cannabis, a California cannabis brand, in a $69 million stock and cash deal.

California cannabis company Vibe Bioscience is set to acquire Cathedral Asset Holding Corporation, a wholly-owned subsidiary of Ventura Cannabis and Wellness Corp.

The FDA has expanded the label of Epidiolex, the first CBD-based medication approved by the federal agency, to treat seizures resulting from tuberous sclerosis complex.

Hawthorne, an indoor cultivation and hydroponics brand subsidiary of Scotts Miracle-Gro, reported 72 percent growth for the third quarter, which ended June 27, 2020.

Curaleaf has successfully completed its acquisition of Grassroots to become the largest vertically-integrated cannabis operator in the country.

iAnthus Capital Holdings, Inc. has announced a recapitalization plan that would leave shareholders either 2.75 percent of the company or nothing.

During the nearly two years of federal legalization in Canada, no single cannabis brand has earned more than 41 percent recognition among consumers.

The SEC has ordered a halt to the High Times IPO after the company missed its annual report deadline in June; recent marketing material, however, suggests that fundraising efforts are still underway.

Collective Growth Corp., the new hemp investment and acquisition venture headed by veteran cannabis CEO Bruce Linton, raised $150 million in its recent IPO.

Cannabis companies are paying insurance rates that are up to seven times higher than other industries with many citing a rise in U.S. lawsuits against publicly traded cannabis firms.

The Dixie Elixirs brand in Colorado — one of the cannabis industry’s most established edibles brands — announced it would change its name to drop the historically racist term “Dixie.”

Florida-based Jushi Inc. is set to acquire Vireo Health International’s cultivation-processor facilities in Pennsylvania in a $37 million deal.

Toronto-based Halo Labs, which serves consumers in both Canada and multiple U.S. state markets, reported a 49 percent decrease in revenue during the first quarter of 2020.

MedMen’s embattled co-founders Andrew Modlin and Adam Bierman have stepped down from their roles on the company’s board of directors.

Florida medical cannabis company Bluma Wellness Inc. is now trading on the Canadian Securities Exchange under the BWEL.U symbol.

Cresco Labs has appointed Michele Roberts, head of the NBA Players Association, to its board of directors; she is the first woman and person of color appointed to the company’s board.

Hightimes Holding Corp. announced a partnership with Red, White & Bloom to create High Times-branded dispensaries and develop cannabis products in Michigan, Illinois, and Florida.

Vireo Health has terminated its employment of veteran cannabis executive Bruce Linton.

Denver-based Schwazze is set to acquire 14 Star Buds locations throughout Colorado including 13 dispensaries and one cultivation site.

FSD Pharma has received FDA permission to design and submit an application for a new trial using a synthetic cannabinoid-based drug in the treatment of COVID-19.

Florida MCBD is suing New York-based Columbia Care claiming a pattern of wrongful interference as Columbia worked to secure a Florida cannabis business license.

Harborside in California is continuing its challenge of the federal tax code 280E, which the company’s legal team says is unconstitutional and runs afoul of the 16th Amendment.